Cargando…

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of this type of cancer frequently hamper the process of determining clinical presentation and predicting therapy effectiveness. The tumor can spontaneously regress without treatment or actively develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kholodenko, Irina V., Kalinovsky, Daniel V., Doronin, Igor I., Deyev, Sergey M., Kholodenko, Roman V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079467/ https://www.ncbi.nlm.nih.gov/pubmed/30116755 http://dx.doi.org/10.1155/2018/7394268

Ejemplares similares

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
por: Kalinovsky, Daniel V, et al.
Publicado: (2022)

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
por: V. Kholodenko, Irina, et al.
Publicado: (2019)

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
por: Sorokin, Maxim, et al.
Publicado: (2020)

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
por: Doronin, Igor I, et al.
Publicado: (2014)

Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
por: Kholodenko, Irina V., et al.
Publicado: (2022)

The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
por: Kholodenko, Irina V., et al.
Publicado: (2019)

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Targets and Antibody Formats for Immunotherapy of Neuroblastoma
por: Park, Jeong A., et al.
Publicado: (2020)

Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases
por: Kholodenko, Irina V., et al.
Publicado: (2017)

Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death
por: Kholodenko, Irina V., et al.
Publicado: (2022)

Cell-based therapies of liver diseases: age-related challenges
por: Yarygin, Konstantin N, et al.
Publicado: (2015)

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
por: George, S. L., et al.
Publicado: (2020)

Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022)

New limits on heavy neutrino from NA62
por: Kholodenko, Sergey
Publicado: (2017)

LHCb ECAL upgrade II
por: Kholodenko, Sergey
Publicado: (2021)

Система сцинтилляционных годоскопов эксперимента NA62
por: Kholodenko, Sergey
Publicado: (2022)

The Origin of the Variola Virus
por: Babkin, Igor V., et al.
Publicado: (2015)

Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data
por: Sorokin, Maxim, et al.
Publicado: (2018)

Caspases and p38 MAPK Regulate Endothelial Cell Adhesiveness for Mesenchymal Stem Cells
por: Potapova, Irina A., et al.
Publicado: (2013)

Neuroblastoma: an ongoing cold front for cancer immunotherapy
por: Kennedy, Paul T, et al.
Publicado: (2023)

Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells
por: Yu, Eun Young, et al.
Publicado: (2022)

Von willebrand factor increases endothelial cell adhesiveness for human mesenchymal stem cells by activating p38 mitogen-activated protein kinase
por: Potapova, Irina A, et al.
Publicado: (2010)

The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
por: Huang, Shaohui, et al.
Publicado: (2022)

Recent advances in the developmental origin of neuroblastoma: an overview
por: Ponzoni, Mirco, et al.
Publicado: (2022)

Origin and mechanism of neuroblastoma
por: Tsubota, Shoma, et al.
Publicado: (2017)

New veto hodoscope ANTI-0 for the NA62 experiment at CERN
por: Danielsson, H., et al.
Publicado: (2020)

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
por: Vanichapol, Thitinee, et al.
Publicado: (2018)

Hopes on immunotherapy targeting B7-H3 in neuroblastoma
por: Pulido, Rafael, et al.
Publicado: (2022)

Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2018)

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model
por: Sokolova, Evgeniya A., et al.
Publicado: (2019)

ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Activating mutations in ALK provide a therapeutic target in neuroblastoma
por: George, Rani E., et al.
Publicado: (2008)

Targeting autophagy in neuroblastoma
por: Huang, Siqi, et al.
Publicado: (2020)

Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?
por: Yarygin, Konstantin N., et al.
Publicado: (2021)

Protein Interactome of Amyloid-β as a Therapeutic Target
por: Lazarev, Vladimir F., et al.
Publicado: (2023)

TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype
por: Kim, Yan S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c32qnnun60rbvsc1prv53opdg8